Biotech Company With Clinical Operations Developing Psychedelic Medicine To Treat Addiction

First 3 UK Clinics Opened In 2021, Targeting 20 Clinics By 2024 ~$100M In Revenue

Free
Discussion Forum: Awakn Life Sciences Corp.
List Message View
Thread Message View
New Message
Message Title
Rating
Author / Date
Icon agoracom VIDEO - Ground Breaking Ketamine Trial Reduces Mortality From 1/8 To 1/80 In Alcohol Use Disorder

AGORACOM-Multimedia
Jan 13, 2022 10:06AM
Icon agoracom Awakn Life Sciences Announces Positive Results from Phase II A/B Ketamine-Assisted Therapy for Treatment of Alcohol Use Disorder Trial

AGORACOM-NR
Jan 11, 2022 07:30AM
Icon agoracom Awakn Life Sciences Expands World's First Ketamine Study Beyond Gambling Disorder to Include Additional Behavioral Addictions

AGORACOM-NR
Jan 05, 2022 07:30AM
Icon agoracom Awakn Life Sciences Announces Voluntary Lock-up Agreement Extension with Management, Board of Directors and Key Shareholders

AGORACOM-NR
Jan 04, 2022 08:28AM
Icon agoracom MEDIA: Awakn Life Sciences’ new psychedelic drug treatment for alcohol addiction moving to clinical trial

AGORACOM
Dec 23, 2021 09:39AM
Icon agoracom MEDIA: Is the NHS ready to embrace psychedelics as medicine?

AGORACOM
Dec 22, 2021 11:14AM
Icon agoracom Awakn Life Sciences Reports Fiscal Third Quarter 2021 Financial Results and Business Highlights

AGORACOM-NR
Dec 15, 2021 07:30AM
Icon agoracom Awakn Life Sciences Appoints Former EVP & Chief Commercial Officer of Gilead Sciences, Paul Carter, as...

AGORACOM-NR
Dec 14, 2021 07:30AM
Icon agoracom Awakn Life Sciences to Participate at Upcoming December Conferences

AGORACOM-NR
Dec 03, 2021 07:45AM
Icon agoracom Awakn Life Sciences Strengthens Executive Leadership Team

AGORACOM-NR
Nov 30, 2021 07:30AM
Icon agoracom EXCLUSIVE: This Company Hopes to Take an Innovative Approach To Treat Addiction

AGORACOM
Nov 22, 2021 09:02AM
Icon agoracom The Psychedelic Diaries Podcast - #018 Anthony Tennyson: a mental health revolution

AGORACOM
Nov 19, 2021 08:54AM
Icon agoracom ALL-TIME HIGH ALERT: Awakn Life Sciences (AWKN: NEO) (AWKNF: OTCQB) Up 2% On 119K Shares

AGORACOM-NR
Nov 18, 2021 04:20PM
Icon agoracom MEDIA: Consolidation Coming In Psychedelics

AGORACOM
Nov 18, 2021 12:25PM
Icon agoracom Awakn Life Sciences Signs MOU with NHS (Devon Partnership NHS Trust) and University of Exeter with a View of Increasing Access to Psychedelic-Assisted

AGORACOM-NR
Nov 16, 2021 07:43AM
Icon agoracom AGORACOM Small Cap 60: Why is Awakn Targeting The UK and EU

AGORACOM
Nov 11, 2021 10:30AM
Icon agoracom AGORACOM Small Cap 60: Awakn (AWKN: NEO) Is Addressing The Most Significant Medical Need of Modern Times

AGORACOM
Nov 05, 2021 03:59PM
Icon agoracom Awakn Life Sciences Announces the Findings from the Phase II A/B Study Are to Be Published in the American Journal of Psychiatry

AGORACOM-NR
Nov 04, 2021 07:40AM
Icon agoracom AGORACOM Small Cap 60: What Action Is Awakn Taking to Target Alcohol Disorder?

AGORACOM
Nov 03, 2021 11:31AM
Icon agoracom Awakn Life Sciences to Participate at the Wonderland: Miami Conference in November 2021

AGORACOM-NR
Nov 02, 2021 07:30AM
New Message